JW Shinyak Corporation (KQ:067290) — Market Cap & Net Worth
Market Cap & Net Worth: JW Shinyak Corporation (067290)
JW Shinyak Corporation (KQ:067290) has a market capitalization of $98.55 Million (₩145.42 Billion) as of September 18, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #19318 globally and #954 in its home market, demonstrating a -10.03% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying JW Shinyak Corporation's stock price ₩3500.00 by its total outstanding shares 41547700 (41.55 Million). Also see balance sheet size of JW Shinyak Corporation for a full breakdown of the balance sheet.
JW Shinyak Corporation Market Cap History: 2015 to 2026
JW Shinyak Corporation's market capitalization history from 2015 to 2026. Data shows change from $189.17 Million to $98.55 Million (-3.79% CAGR). Also see JW Shinyak Corporation cash conversion from operations for how efficiently the company converts equity into cash flow.
Index Memberships
JW Shinyak Corporation is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Kosdaq Composite Index
KOSDAQ
|
$233.34 Billion | 0.04% | #386 of 1384 |
|
Kosdaq Composite Index
KQ11
|
$233.34 Billion | 0.04% | #386 of 1384 |
Weight: JW Shinyak Corporation's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
JW Shinyak Corporation Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how JW Shinyak Corporation's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check JW Shinyak Corporation stock price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.00x
JW Shinyak Corporation's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.01x
JW Shinyak Corporation's market cap is 0.01 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $189.17 Million | $76.95 Billion | $255.85 Million | 0.00x | 0.74x |
| 2016 | $180.85 Million | $83.38 Billion | -$481.75 Million | 0.00x | N/A |
| 2017 | $191.58 Million | $76.84 Billion | -$6.08 Billion | 0.00x | N/A |
| 2018 | $151.58 Million | $91.78 Billion | -$7.51 Billion | 0.00x | N/A |
| 2019 | $111.11 Million | $102.53 Billion | $1.44 Billion | 0.00x | 0.08x |
| 2020 | $145.69 Million | $103.80 Billion | -$6.45 Billion | 0.00x | N/A |
| 2021 | $103.18 Million | $100.97 Billion | $883.78 Million | 0.00x | 0.12x |
| 2022 | $97.34 Million | $102.71 Billion | $1.40 Billion | 0.00x | 0.07x |
| 2023 | $69.83 Million | $104.23 Billion | -$37.36 Billion | 0.00x | N/A |
| 2024 | $42.49 Million | $93.01 Billion | $5.08 Billion | 0.00x | 0.01x |
Competitor Companies of 067290 by Market Capitalization
Companies near JW Shinyak Corporation in the global market cap rankings as of September 18, 2026. Review 067290 intangible-adjusted equity ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to JW Shinyak Corporation by market ranking:
- Sam Chun Dang Pharm. Co. Ltd (KQ:000250): Ranked #5752 globally with a market cap of $2.26 Billion USD ( ₩3.34 Trillion KRW).
- ST Pharm Co.Ltd (KQ:237690): Ranked #8322 globally with a market cap of $1.14 Billion USD ( ₩1.69 Trillion KRW).
- NatureCell Co.Ltd (KQ:007390): Ranked #9400 globally with a market cap of $895.63 Million USD ( ₩1.32 Trillion KRW).
- Oscotec Inc (KQ:039200): Ranked #10937 globally with a market cap of $654.17 Million USD ( ₩965.30 Billion KRW).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #5752 | Sam Chun Dang Pharm. Co. Ltd | KQ:000250 | $2.26 Billion | ₩156100.00 |
| #8322 | ST Pharm Co.Ltd | KQ:237690 | $1.14 Billion | ₩90400.00 |
| #9400 | NatureCell Co.Ltd | KQ:007390 | $895.63 Million | ₩24900.00 |
| #10937 | Oscotec Inc | KQ:039200 | $654.17 Million | ₩34350.00 |
JW Shinyak Corporation Historical Marketcap From 2015 to 2026
Between 2015 and today, JW Shinyak Corporation's market cap moved from $189.17 Million to $ 98.55 Million, with a yearly change of -3.79%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩98.55 Million | +64.32% |
| 2025 | ₩59.97 Million | +41.15% |
| 2024 | ₩42.49 Million | -39.15% |
| 2023 | ₩69.83 Million | -28.26% |
| 2022 | ₩97.34 Million | -5.66% |
| 2021 | ₩103.18 Million | -29.18% |
| 2020 | ₩145.69 Million | +31.13% |
| 2019 | ₩111.11 Million | -26.70% |
| 2018 | ₩151.58 Million | -20.88% |
| 2017 | ₩191.58 Million | +5.93% |
| 2016 | ₩180.85 Million | -4.40% |
| 2015 | ₩189.17 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 17th, 2026 the market cap of JW Shinyak Corporation was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $98.55 Million USD |
| MoneyControl | $98.55 Million USD |
| MarketWatch | $98.55 Million USD |
| marketcap.company | $98.55 Million USD |
| Reuters | $98.55 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About JW Shinyak Corporation
JW Shinyak Corporation, a pharmaceutical company, engages in the production and sale of medicines and medical supplies in South Korea. The company offers pharmaceutical products in the areas of dermatology, urology, pediatrics, otolaryngology, etc.; and cardiovascular, gastrointestinal, urinary, NSAIDs, antibiotics, anti-fungal, anti-viral, respiratory, antihistamines, steroid hormone, anti-obesi… Read more